Please login to the form below

MEDI1814

This page shows the latest MEDI1814 news and features for those working in and with pharma, biotech and healthcare.

Biogen rises on more positive data for Alzheimer's candidate

compounds. . Last week, it partnered with AstraZeneca (AZ) on MEDI1814, an antibody against amyloid-beta 42 (Aβ42) in phase I trials, and is also working with AZ on BACE inhibitor AZD3293,

Latest news

Lilly taps AstraZeneca for another anti-amyloid drug

Lilly and AZ will collaborate on the development of MEDI1814, an antibody against amyloid-beta 42 (Aβ42), which is currently in phase I trials. ... MEDI1814 dose-dependently reduces levels of the Aβ42 peptide - which is thought to be particularly

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director – Healthcare Marketing – Berks: Salary TBC

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Medical Writer: Salary TBC

Senior Medical Writer: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Account Director development role to Business Director, H...: Excellent package

Account Director – Health Policy – Global Agency: Salary TBC

Associate Director: £75, 000-90, 000

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Account Manager / Senior Account Manager: 35, 000-40, 000

Global Business Development Director – Health Education: excellent commission

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Director, Medical Education: Salary TBC

Account Manager / Account Director: Competative

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

NHS regional footprints: What to expect from 2019...
Not another weight-loss ad: Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...